Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Mallinckrodt
Merck
Teva
Dow
Julphar
Fish and Richardson
AstraZeneca
Harvard Business School
Farmers Insurance

Generated: December 12, 2017

DrugPatentWatch Database Preview

Mesna - Generic Drug Details

« Back to Dashboard

What are the generic sources for mesna and what is the scope of mesna patent protection?

Mesna
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Mylan Institutional, Mylan Labs Ltd, Sagent Pharms, Teva Pharms Usa, West-ward Pharms Int, and Baxter Hlthcare, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for mesna. Five suppliers are listed for this compound.

Pharmacology for mesna

Medical Subject Heading (MeSH) Categories for mesna

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms IntMESNAmesnaINJECTABLE;INTRAVENOUS075739-001Jan 9, 2004APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalMESNAmesnaINJECTABLE;INTRAVENOUS076488-001Mar 8, 2012APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Labs LtdMESNAmesnaINJECTABLE;INTRAVENOUS203364-001Jul 18, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaMESNAmesnaINJECTABLE;INTRAVENOUS075811-001Apr 26, 2001APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sagent PharmsMESNAmesnaINJECTABLE;INTRAVENOUS090913-001Apr 13, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Baxter HlthcareMESNEXmesnaTABLET;ORAL020855-001Mar 21, 2002RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Baxter HlthcareMESNEXmesnaINJECTABLE;INTRAVENOUS019884-001Dec 30, 1988APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaMESNAmesnaINJECTABLE;INTRAVENOUS075764-001Apr 27, 2001APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mesna

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter HlthcareMESNEXmesnaINJECTABLE;INTRAVENOUS019884-001Dec 30, 1988► Subscribe► Subscribe
Baxter HlthcareMESNEXmesnaTABLET;ORAL020855-001Mar 21, 2002► Subscribe► Subscribe
Baxter HlthcareMESNEXmesnaTABLET;ORAL020855-001Mar 21, 2002► Subscribe► Subscribe
Baxter HlthcareMESNEXmesnaINJECTABLE;INTRAVENOUS019884-001Dec 30, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Johnson and Johnson
Harvard Business School
Covington
Medtronic
QuintilesIMS
Chubb
Farmers Insurance
Novartis
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot